Results 1 - 4 of 4 Search Tips

Practical experience with rituximab subcutaneous

08 October 2015

Cancer Nursing Practice

CPD

Treatment regimens involving the monoclonal anti-CD20 antibody rituximab are the standard of care for patients with CD20-positive non-Hodgkin lymphoma (NHL). It has...

An overview of non-Hodgkin’s lymphoma

11 February 2014

Cancer Nursing Practice

CPD

Non-Hodgkin’s lymphoma is a heterogeneous group of lymphoproliferative malignancies with differing patterns of behaviour and responses to treatment. Chemotherapy,...

Investigating overall quality of life in patients with diffuse large B-cell lymphoma undergoing CAR T-cell therapy

21 May 2024

Cancer Nursing Practice

evidence and practice

Background Some adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) are eligible for chimeric antigen receptor T-cell (CAR T-cell) therapy....

Continuing professional development: lymphoma in primary care

07 May 2019

Primary Health Care

blood cancer

Lymphoma encompasses a heterogeneous group of haematological malignancies that require complex management. Patients with lymphoma experience a wide range of...